Neostigmine methylsulfate manufacturers

Filters

Filters

Filters , active

Country of origin : China
None products found

neostigmine methylsulfate

Solution for injection 0.5 mg/1 ml, 2 mg/4 ml - 1 ml, 4 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #36625

A pharmaceutical manufacturer engaged in the research, development, manufacture and commercialization of a variety of pharmaceutical products, including finished dosage forms such as capsules, tablets and injections as well as active pharmaceutical ingredients. The company focuses on multiple therapeutic areas including diabetic, cardiovascular, oncology, anesthetic and analgesic treatments, and operates manufacturing facilities that have passed relevant GMP standards to support quality and compliance in production of its pharmaceutical products.

neostigmine methylsulfate

Solution for injection 0.5 mg/1 ml, 1 mg/2 ml, 2 mg/4 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Manufacturer #34185

Established in 1994, this innovative R&D and manufacturing company focuses on the pharmaceutical and health sectors. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards, operating sophisticated drug production facilities that meet cGMP specifications from regulatory bodies such as NMPA, FDA, and EMA. The company's diverse portfolio includes biologics, small molecules, synthetic biologics, and special traditional Chinese medicines (TCMs), with over 300 product approvals across various categories. Its products are distributed in more than 40 countries and regions, including Singapore, South Korea, Italy, and China.

neostigmine methylsulfate

Solution for injection 0.5 mg/ml, 1 mg/2 ml, 2 mg/4 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
ANVISA, China, Malaysia
Manufacturer #18713
This pharmaceutical company, headquartered in a major Chinese city, focuses on research, development, manufacturing, and distribution of high-quality pharmaceuticals globally. Their product portfolio includes prescription medications like Ginkgolide injection, Clindamycin phosphate for injection, Ambroxol hydrochloride injection, and Enoxaparin sodium for injection. Key therapy areas include neurological-psychiatric disorders, cardiocerebrovascular diseases, respiratory illnesses, digestive issues, and antibiotics. The company emphasizes GMP certifications and holds patents for its products. They serve markets in regions like the EU, North America, and beyond.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.